Since the absence of previous studies that define the HER2 positivity in CDC, we refer to the most recent ASCO/CAP 2018 guidelines [25] to assess the HER2 protein expression by IHC and HER2 gene amplification by FISH in the tumor specimens. The gene discussed is ERBB2; the disease is neoplasm.